Moolec Science (MLEC) EBT Margin (2022 - 2024)

Moolec Science (MLEC) reported EBT Margin of 81.21% for Q4 2024, up 71982.0% on a YoY basis from N/an in Q1 2024, and up 34.94% sequentially from 124.82% in Q3 2024.

Moolec Science (MLEC) EBT Margin (2022 - 2024) Analysis & Trends

Moolec Science (MLEC) has 3 years of EBT Margin data on file, last reported at 81.21% in Q4 2024.

  • For the quarter ending Q4 2024, EBT Margin rose 71982.0% year-over-year to 81.21%; the trailing twelve-month figure through Dec 2024 stood at 110.09% (down 13511.0% YoY), and the FY2024 full-year result was 148.61%, up 559953.0% from the prior year.
  • EBT Margin advanced to 81.21% in Q4 2024, from 124.82% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 501839.99% in Q4 2022 to a low of 74622.65% in Q2 2022.
  • A 3-year average of 36480.54% and a median of 70.83% in 2024 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 7463240 bps in 2023, while the deepest fall reached 50264102 bps in 2023.
  • Tracing MLEC's EBT Margin over 3 years: stood at 501839.99% in 2022, then tumbled by 100 bps to 801.03% in 2023, then surged by 90 bps to 81.21% in 2024.
  • Business Quant data shows MLEC's EBT Margin at 81.21% in Q4 2024, 124.82% in Q3 2024, and 213.92% in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 67,222.41 Bn 67,222.13 Bn - -
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -
4 BeOne Medicines 472.06 Bn 467.27 Bn 1.35 Bn 17.13%
5 Vertex Pharmaceuticals 122.10 Bn 114.85 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 70.00 Bn 61.25 Bn 3.31 Bn 23.05%
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn 34.77%
9 Alnylam Pharmaceuticals 37.50 Bn 34.50 Bn 959.66 Mn 18.99%
10 Moolec Science 5.35 Bn 5.35 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -81.21%
Sep 30, 2024 -124.82%
Jun 30, 2024 -213.92%
Mar 31, 2024 -60.44%
Dec 31, 2023 -801.03%
Sep 30, 2023 -103.81%
Jun 30, 2023 9.74%
Mar 31, 2023 1,271.78%
Dec 31, 2022 501,839.99%
Sep 30, 2022 6,273.27%
Jun 30, 2022 -74,622.65%
Mar 31, 2022 4,379.63%